GlassScriptPhysician profile
Chase Krumins
NPI 1710469614
$4,966.68
in general payments reported to CMS, 2019-2025
30 companies · $1,252 in 2025
The $1,252 reported for 2025 was more than what 92% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $643 · 2022: $336 · 2023: $792 · 2024: $1,943 · 2025: $1,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,602 · Consulting Fee: $1,375 · Travel and Lodging: $10.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,601.95 |
| Consulting Fee | $1,375.00 |
| Travel and Lodging | $10.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fujifilm Sonosite, INC. | $1,375.00 | 2024-2025 | Sonosite Px Ultrasound System |
| Spineology INC. | $468.04 | 2021-2023 | Optimesh Expandable Interbody Fusion System |
| Abbvie INC. | $280.03 | 2023-2025 | |
| Penumbra, INC. | $274.28 | 2023-2024 | Penumbra System |
| Teva Pharmaceuticals USA, INC. | $258.84 | 2022-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Ucb, INC. | $247.24 | 2024-2025 | Rystiggo, Zilbrysq, Briviact |
| Lilly USA, LLC | $224.18 | 2023-2025 | Kisunla, Amyvid |
| Alnylam Pharmaceuticals INC. | $202.68 | 2024-2025 | Amvuttra, Onpattro |
| Cerapedics INC. | $182.76 | 2023 | I-Factor Peptide Enhanced Bone Graft |
| Nevro Corp. | $171.44 | 2021-2022 | |
| Ethicon US, LLC | $163.55 | 2022-2024 | Stratafix, Dermabond Prineo |
| Si-Bone, INC. | $152.01 | 2025 | |
| Pfizer INC. | $113.80 | 2023-2025 | |
| Eisai INC. | $110.25 | 2024-2025 | |
| Medtronic, INC. | $102.92 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $99.86 | 2023-2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Lundbeck LLC | $67.60 | 2024 | Vyepti |
| Orthofix Medical, INC. | $58.30 | 2021 | |
| Acadia Pharmaceuticals INC | $54.94 | 2024 | Nuplazid |
| Novartis Pharmaceuticals Corporation | $51.98 | 2024 | |
| Neurelis, INC. | $51.15 | 2023-2024 | Valtoco |
| Boston Scientific Corporation | $44.77 | 2023 | Vercise |
| Stryker Corporation | $39.61 | 2021 | |
| Upsher-Smith Laboratories LLC | $32.79 | 2023 | |
| Microvention, INC. | $26.80 | 2025 | Stent |
| Depuy Synthes Sales INC. | $26.39 | 2022 | |
| Impel Pharmaceuticals INC. | $24.52 | 2023 | Trudhesa |
| Tanabe Pharma America, INC. | $23.77 | 2023 | |
| Argenx US, INC. | $20.52 | 2023 | Vyvgart Hytrulo |
| Abbott Laboratories | $16.66 | 2023 | Xact |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chase Krumins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.